The current work significantly promotes our understanding of the mRNA modification metabolic effects by analyzing both of the mRNA modification targets of FTO (m6A and m6Am) in two different in vivo obesity mouse models. The gene discussed is FTO; the disease is obesity due to melanocortin 4 receptor deficiency.